Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$29.97 USD
-1.50 (-4.77%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $29.94 -0.03 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.08 | 0.00% |
Earnings Summary
For their last quarter, Castle Biosciences (CSTL) reported earnings of $0.31 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 293.75%. Look out for CSTL's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 69.23%.
Earnings History
Price & Consensus
Zacks News for CSTL
Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
CSTL: What are Zacks experts saying now?
Zacks Private Portfolio Services